image dons

I make a donation

ALPHEUS

Evaluating the effect of a loading dose of Ticagrelor compared to Clopidogrel to decrease ischemic events in patients undergoing a scheduled coronary angioplasty.

Terminée

Remerciements de la Famille COLLET

Prix de Recherche Pr Jean-Philippe COLLET

La Grande Journée du Coeur (13 juin 2023)
Attention : plus que quelques places restantes !

La Grande Journée du Coeur (mardi 13 juin 2023)
Les présentations sont en ligne

Colloquium "Rythme et conduction" (23 avril 2024)
Inscrivez-vous !

logo étude

objectif

Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS) : a randomised, open-label, phase 3b trial

date de réalisation

2017

nombre de patients

1900

nombre de centres participants

International multicentric trial

type de financement

Private (AstraZeneca)

Référence

NCT02617290

A study conducted by Fonds de Dotation ACTION.
Find out details and results on the dedicated page

ALPHEUS conducted by Fonds de Dotation ACTION

Autres études

+

BIO-TAVI

En cours

Correlation between the platelet reactivity, the von Willebrand factor and bleeding and thrombotic events occuring during the year following TAVI
Lire la suite
+

AMUNDSEN

En cours

A phase IV, multicentric, randomized, real-world pragmatic study that compares a strategy of early LDL reduction with anti-PCSK9 in patients defined as extreme high risk by 2019 ESC/EAS guidelines vs....
Lire la suite
+

AFIJI

En cours

Impact of genetics on occuring of coronary diseases in young patients and the pharmacogenetic of clopidogrel and its impact on the prognosis of patients having had angioplasty
Lire la suite